NT PHARMA: Zhang Bozhi appointed as CEO
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, NT PHARMA announced that as the company's business scale expands and considering the needs for the next phase of the company's development, Mr. Wu Tie wishes to dedicate more time to focus on the group's development strategy and other matters, therefore he has resigned from the position of Chief Executive Officer, effective from May 19, 2025. Mr. Wu Tie will continue to serve as the Chairman of the Board and Executive Director. Mr. Zhang Bozhi has been appointed as the Chief Executive Officer, effective from May 19, 2025
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments